BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 29542855)

  • 1. Mesoscopic characterization of prostate cancer using Raman spectroscopy: potential for diagnostics and therapeutics.
    Aubertin K; Trinh VQ; Jermyn M; Baksic P; Grosset AA; Desroches J; St-Arnaud K; Birlea M; Vladoiu MC; Latour M; Albadine R; Saad F; Leblond F; Trudel D
    BJU Int; 2018 Aug; 122(2):326-336. PubMed ID: 29542855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image-guided Raman spectroscopy navigation system to improve transperineal prostate cancer detection. Part 1: Raman spectroscopy fiber-optics system and in situ tissue characterization.
    Picot F; Shams R; Dallaire F; Sheehy G; Trang T; Grajales D; Birlea M; Trudel D; Ménard C; Kadoury S; Leblond F
    J Biomed Opt; 2022 Sep; 27(9):. PubMed ID: 36045491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raman spectroscopy system for real-time diagnosis of clinically significant prostate cancer tissue.
    van Breugel SJ; Low I; Christie ML; Pokorny MR; Nagarajan R; Holtkamp HU; Srinivasa K; Amirapu S; Nieuwoudt MK; Simpson MC; Zargar-Shoshtari K; Aguergaray C
    J Biophotonics; 2023 May; 16(5):e202200334. PubMed ID: 36715344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface-enhanced Raman spectroscopy of preoperative serum samples predicts Gleason grade group upgrade in biopsy Gleason grade group 1 prostate cancer.
    Qian H; Shao X; Zhu Y; Fan L; Zhang H; Dong B; Wang Y; Xu F; Zhen W; Kang X; Chen N; Liu S; Pan J; Xue W
    Urol Oncol; 2020 Jun; 38(6):601.e1-601.e9. PubMed ID: 32241690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice.
    Tosoian JJ; Druskin SC; Andreas D; Mullane P; Chappidi M; Joo S; Ghabili K; Agostino J; Macura KJ; Carter HB; Schaeffer EM; Partin AW; Sokoll LJ; Ross AE
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):228-233. PubMed ID: 28117387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image-guided Raman spectroscopy navigation system to improve transperineal prostate cancer detection. Part 2: in-vivo tumor-targeting using a classification model combining spectral and MRI-radiomics features.
    Grajales Lopera DO; Picot F; Shams R; Dallaire F; Sheehy G; Alley S; Barkati M; Delouya G; Carrier JF; Birlea M; Trudel D; Leblond F; Ménard C; Kadoury S
    J Biomed Opt; 2022 Sep; 27(9):. PubMed ID: 36085571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-modality probe intended for prostate cancer detection combining Raman spectroscopy and tactile resonance technology--discrimination of normal human prostate tissues ex vivo.
    Nyberg M; Jalkanen V; Ramser K; Ljungberg B; Bergh A; Lindahl OA
    J Med Eng Technol; 2015 Apr; 39(3):198-207. PubMed ID: 25762203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of expressed prostatic secretion and serum using surface-enhanced Raman spectroscopy for the noninvasive detection of prostate cancer, a preliminary study.
    Shao X; Pan J; Wang Y; Zhu Y; Xu F; Shangguan X; Dong B; Sha J; Chen N; Chen Z; Wang T; Liu S; Xue W
    Nanomedicine; 2017 Apr; 13(3):1051-1059. PubMed ID: 27979746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.
    Grosset AA; Dallaire F; Nguyen T; Birlea M; Wong J; Daoust F; Roy N; Kougioumoutzakis A; Azzi F; Aubertin K; Kadoury S; Latour M; Albadine R; Prendeville S; Boutros P; Fraser M; Bristow RG; van der Kwast T; Orain M; Brisson H; Benzerdjeb N; Hovington H; Bergeron A; Fradet Y; Têtu B; Saad F; Leblond F; Trudel D
    PLoS Med; 2020 Aug; 17(8):e1003281. PubMed ID: 32797086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-enhanced Raman spectroscopy of serum accurately detects prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL.
    Chen N; Rong M; Shao X; Zhang H; Liu S; Dong B; Xue W; Wang T; Li T; Pan J
    Int J Nanomedicine; 2017; 12():5399-5407. PubMed ID: 28794631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human feasibility study of fluorescence spectroscopy guided optical biopsy needle for prostate cancer diagnosis.
    Werahera PN; Jasion EA; Liu Y; Daily JW; Arangua P; Jones C; Nash SR; Morrell M; Crawford ED
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():7358-61. PubMed ID: 26737991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a high throughput (HT) Raman spectroscopy method for rapid screening of liquid blood plasma from prostate cancer patients.
    Medipally DK; Maguire A; Bryant J; Armstrong J; Dunne M; Finn M; Lyng FM; Meade AD
    Analyst; 2017 Apr; 142(8):1216-1226. PubMed ID: 28001146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulated Raman histology, a novel method to allow for rapid pathologic examination of unprocessed, fresh prostate biopsies.
    Mannas MP; Jones D; Deng FM; Hoskoppal D; Melamed J; Orringer DA; Taneja SS
    Prostate; 2023 Aug; 83(11):1060-1067. PubMed ID: 37154588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy.
    Abdollah F; Scattoni V; Raber M; Roscigno M; Briganti A; Suardi N; Gallina A; Capitanio U; Freschi M; Salonia A; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2011 Aug; 108(3):366-71. PubMed ID: 21087451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of fiberoptic near-infrared raman spectroscopy for diagnosis of bladder and prostate cancer.
    Crow P; Molckovsky A; Stone N; Uff J; Wilson B; WongKeeSong LM
    Urology; 2005 Jun; 65(6):1126-30. PubMed ID: 15913721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
    Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
    Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo MRI evaluation of prostate cancer: Localization and margin status prediction of prostate cancer in fresh radical prostatectomy specimens.
    Heidkamp J; Hoogenboom M; Kovacs IE; Veltien A; Maat A; Sedelaar JPM; Hulsbergen-van de Kaa CA; Fütterer JJ
    J Magn Reson Imaging; 2018 Feb; 47(2):439-448. PubMed ID: 28580659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of bladder cancer by low-resolution fiber-optic Raman spectroscopy.
    Chen H; Li X; Broderick N; Liu Y; Zhou Y; Han J; Xu W
    J Biophotonics; 2018 Sep; 11(9):e201800016. PubMed ID: 29797794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of prostate cancer by Raman spectroscopy: A multivariate study on patients with normal and altered PSA values.
    Correia NA; Batista LTA; Nascimento RJM; Cangussú MCT; Crugeira PJL; Soares LGP; Silveira L; Pinheiro ALB
    J Photochem Photobiol B; 2020 Mar; 204():111801. PubMed ID: 31978674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.